Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 07 May 2026 | Chiara Galiffa Cabinet member | Latest developments in EU-US relations | SRC |
| 13 Nov 2025 | Anne Simon Head of Unit | Challenges encountered by BD in the production line of syringes in Europe | — |
| 13 Nov 2025 | Anne Simon Head of Unit | Challenges encountered by BD in the production line of syringes in Europe | SRC |
| 23 Oct 2025 | Jana Dabbelt Cabinet member | Medical waste | SRC |
| 23 Oct 2025 | Jana Dabbelt Cabinet member | Medical waste | — |
| 06 Oct 2025 | Chiara Galiffa Cabinet member | EU – US relations | SRC |
| 06 Oct 2025 | Chiara Galiffa Cabinet member | EU – US relations | — |
| 27 Aug 2025 | Adam Romanowski Cabinet member | EU-US trade and investment relations in the medical technology sector | SRC |
| 27 Aug 2025 | Adam Romanowski Cabinet member | EU-US trade and investment relations in the medical technology sector | — |
| 29 Jan 2025 | Chiara Galiffa Cabinet member | EU-US trade | — |
| 29 Jan 2025 | Matthias Jorgensen Head of Unit | Transatlantic trade relations in the second Trump administration. | — |
| 29 Jan 2025 | Sabine Weyand Director-General | Transatlantic trade relations in the second Trump administration. | — |
| 29 Jan 2025 | Chiara Galiffa Cabinet member | EU-US trade | SRC |
| 29 Jan 2025 | Matthias Jorgensen Head of Unit | Transatlantic trade relations in the second Trump administration. | SRC |
| 29 Jan 2025 | Sabine Weyand Director-General | Transatlantic trade relations in the second Trump administration. | SRC |
| 27 Jan 2025 | Ioan-Dragos Tudorache Cabinet member | Policies to improve EU’s business environment and competitiveness, business concerns related to regulatory burdens, and key sectoral challenges. | SRC |
| 27 Jan 2025 | Ioan-Dragos Tudorache Cabinet member | Policies to improve EU’s business environment and competitiveness, business concerns related to regulatory burdens, and key sectoral challenges. | — |
Mission & Goals
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance cellular studies and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.
EU Legislative Interests
Patient Safety, including HAI's, AMR and medication management. MDR & IVDR. Occupational safety and health of healthcare staff. Healthcare efficiency. Environmental safety and regulation, including REACH and the RoHS. EU Public Procurement Directive. The Cross Border Health Directive. HTA Network. e-health. Health screening and early diagnosis. Digitalisation of medication management EU Pharma strategy Europe´s Beating Cancer Plan Digital strategy Women's health and cancer. Health research EU4HEALTH Hemodynamic control and fluid management Medicines Act Pharma Package Workforce Crisis in the EU Critical Medicines Act EU Cardiovascular Disease Plan
Communication Activities
Support of relevant activities undertaken by MedTech Europe Support of the following activities: Protection of healthcare workers from hazardous drugs exposure risks Surgical Site Infections and the importance of appropriate skin antisepsis The role of rapid diagnostics in AMR prevention Medication errors prevention : supporting ECAMET project through EAASM Medicines shortages prevention and management in healthcare providers Support one EU stratgey on patient safety Support recommendations of CAUTI Prevention by scientific associations Support EHMA (European Health Management Association) to advocate for digitalisation of medication management in EU Hospitals Support of Federation of European Academies of Medicines in medication waste project Suport Global Sepsis Alliance in improving awareness , early diagnosis and treatment of Sepsis in Europe Support external urinary systems for females in nursing homes and primary care in Europe Support of one EU strategy on CAUTI and IADs prevention EU Cardiovascular Desease Plan Support European Biosafety Network (EBN) on heathcare workers protection from MSDs
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
MedTech Europe European Alliance for Access to Safe Medicines (EAASM) European Cancer Organization (ECO) Federation of European Academies of Medicine (FEAM) European Patient Safety Foundation (EUPSF) European Sepsis Alliance
Connected Legislation